JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is a leading peer-reviewed journal dedicated to the exploration and advancement of pharmacological therapies related to cardiovascular diseases. With its ISSN 0160-2446 and E-ISSN 1533-4023, this esteemed journal has been at the forefront of cardiovascular research since its inception in 1979, continuously offering insights until 2024. It holds a commendable position in the 2023 category quartiles, classified as Q2 in both Cardiology and Cardiovascular Medicine, as well as Medicine (miscellaneous) and Pharmacology, showcasing its significance within these fields. The journal presents a unique platform for researchers, health professionals, and students to disseminate their findings, fostering an environment of knowledge growth and collaboration in cardiovascular pharmacology. Readers can expect to find high-quality articles that contribute to the body of knowledge in cardiovascular therapies, ensuring they remain informed of the latest advancements and clinical practices. Discover more about this influential publication and its commitment to enhancing cardiovascular health.

Acta Physiologica is a premier, peer-reviewed journal published by WILEY, dedicated to the dissemination of high-quality research across the field of physiology. With an impressive impact factor reflective of its Q1 category ranking in Physiology for 2023, this journal is a vital resource for researchers, professionals, and students alike, seeking to explore the complexities of biological systems. The journal is indexed with a commendable Scopus rank of #18 out of 193 in its category, placing it within the top 10% of its field, which underscores its influence and citation frequency within the academic community. Acta Physiologica publishes a variety of articles that address fundamental physiological concepts, innovative methodologies, and cross-disciplinary research. With its open access options, the journal ensures that cutting-edge knowledge is readily accessible, fostering an environment of collaboration and advancement in the study of physiology. Spanning from 2006 to 2024, the journal continues to be at the forefront of physiological research and education, encouraging the global sharing of knowledge through its comprehensive content.

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, published by Elsevier Science Ltd, is a premier scholarly journal dedicated to advancing the field of cardiology and cardiovascular medicine as well as molecular biology. With an impressive Q1 ranking in both categories as of 2023, the journal boasts a significant influence in the scientific community, evidenced by its Scopus rankings—33rd out of 387 in Cardiology and 65th out of 410 in Molecular Biology. Established in 1970 and continuing to publish groundbreaking research through 2024, the journal’s mission is to disseminate innovative findings that enhance our understanding of cardiovascular health at the molecular and cellular levels. Although it is not an open-access publication, it attracts top-tier research contributions, making it essential reading for researchers, healthcare professionals, and students aiming to stay ahead in the dynamic domains of cardiovascular and molecular biology research.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.

Physiology International is a distinguished journal dedicated to the exploration and advancement of knowledge in the fields of physiology, sports medicine, and rehabilitation. Published by AKADEMIAI KIADO ZRT in Hungary, this open-access journal has been a reliable source of scholarly articles since its inception in 2016, providing valuable insights into both complementary and alternative medicine, as well as traditional medical practices. With an impact factor that situates it in Q2 and Q3 quartiles across related disciplines, including Physical Therapy, Sports Therapy and Rehabilitation and Orthopedics and Sports Medicine, it represents a vital resource for professionals and researchers looking to stay abreast of the latest findings and methodologies. The journal is indexed on Scopus, signifying its credibility and relevance in the medical community. As it continues to develop through 2024, Physiology International invites contributions that challenge existing paradigms and foster innovative approaches to health and wellness, making it an essential platform for advancing the conversation in medical physiology and its applications.

Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

FISH PHYSIOLOGY AND BIOCHEMISTRY, published by Springer, is a leading journal in the fields of aquatic science, biochemistry, and physiology, with an impressive trajectory since its inception in 1986 and continuing through 2024. Operating from the Netherlands, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing innovative studies that explore the physiological and biochemical aspects of fish, contributing significantly to our understanding of aquatic ecosystems and their inhabitants. With a robust impact factor reflected in its Q1 status in Aquatic Science and notable rankings in other relevant categories, FISH PHYSIOLOGY AND BIOCHEMISTRY maintains a strong scholarly influence, evidenced by its Scopus ranking within the top quartiles of various biological sciences disciplines. While the journal does not currently offer open access options, it remains a cornerstone for advancing knowledge and fostering collaboration within the community dedicated to aquatic biology and related fields.

The Journal of Applied Physiology, established in 1948 and published by the American Physiological Society, stands as a cornerstone in the field of physiology and applied health sciences. With an impact factor reflecting its rigorous scholarly contributions, this peer-reviewed journal ranks in the Q1 category for both Medicine (miscellaneous) and Physiology as of 2023, further emphasizing its prestige and relevance. Researchers and practitioners are drawn to its comprehensive scope, which includes physiological and biomechanical responses relevant to health, exercise, and clinical practices, making it an essential resource for advancements in sports science and medical physiology. Though it does not offer Open Access, the journal provides a wealth of high-quality research, with contributions that are crucial for understanding the complexities of human physiology. Its inclusion in Scopus ranks demonstrates a solid commitment to advancing knowledge in the field, appealing to a diverse audience of researchers, professionals, and students committed to exploring the intricate interactions between physiological processes and applied health.